Increased Tryptophan Metabolism Is Associated With Activity of Inflammatory Bowel Diseases.
暂无分享,去创建一个
Michael Krawczak | Philip Rosenstiel | Silke Szymczak | Ateequr Rehman | Stefan Schreiber | Robert Häsler | Florian Tran | S. Szymczak | P. Rosenstiel | M. Krawczak | R. Häsler | M. Schwarz | S. Nikolaus | G. H. Waetzig | J. Bethge | D. Schulte | A. Rehman | F. Tran | Konrad Aden | Susanna Nikolaus | Berenice Schulte | Natalie Al-Massad | Florian Thieme | Dominik M Schulte | Johannes Bethge | Natalie Moll | Gregor Schütze | Markus J Schwarz | Georg H Waetzig | K. Aden | B. Schulte | F. Thieme | N. Moll | S. Schreiber | G. Schütze | Natalie Al-Massad
[1] R. Al-Jaouni,et al. Nutritional deficiencies in patients with Crohn's disease in remission , 2006, Inflammatory bowel diseases.
[2] O. Zinder,et al. Pellagra as the presenting manifestation of Crohn's disease. , 1982, Gastroenterology.
[3] Beeken Wl. Serum tryptophan in Crohn's disease. , 1976 .
[4] Toshifumi Hibi,et al. Novel, Objective, Multivariate Biomarkers Composed of Plasma Amino Acid Profiles for the Diagnosis and Assessment of Inflammatory Bowel Disease , 2012, PloS one.
[5] K. Walczak,et al. Kynurenic acid synthesis and kynurenine aminotransferases expression in colon derived normal and cancer cells , 2011, Scandinavian journal of gastroenterology.
[6] Gerard Clarke,et al. Tryptophan degradation in irritable bowel syndrome: evidence of indoleamine 2,3-dioxygenase activation in a male cohort , 2009, BMC gastroenterology.
[7] P. Rosenstiel,et al. ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation , 2012, Nature.
[8] Y. Mine,et al. l-Tryptophan exhibits therapeutic function in a porcine model of dextran sodium sulfate (DSS)-induced colitis. , 2010, The Journal of nutritional biochemistry.
[9] T. Stone,et al. Levels of purine, kynurenine and lipid peroxidation products in patients with inflammatory bowel disease. , 2003, Advances in experimental medicine and biology.
[10] H. Raspe,et al. Clinical status, psychosocial impairments, medical treatment and health care costs for patients with inflammatory bowel disease (IBD) in Germany: an online IBD registry. , 2013, Journal of Crohn's & colitis.
[11] Russell Pickford,et al. Bimodal plasma metabolomics strategy identifies novel inflammatory metabolites in inflammatory bowel diseases. , 2014, Discovery medicine.
[12] C. Bokemeyer,et al. Nicotinamide treatment ameliorates the course of experimental colitis mediated by enhanced neutrophil-specific antibacterial clearance. , 2014, Molecular nutrition & food research.
[13] Martin Hartmann,et al. Introducing mothur: Open-Source, Platform-Independent, Community-Supported Software for Describing and Comparing Microbial Communities , 2009, Applied and Environmental Microbiology.
[14] U. Grohmann,et al. T cell apoptosis by tryptophan catabolism , 2002, Cell Death and Differentiation.
[15] Xavier Robin,et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves , 2011, BMC Bioinformatics.
[16] L. Varesio,et al. Antiproliferative activity of picolinic acid due to macrophage activation. , 1987, Drugs under experimental and clinical research.
[17] W. Roediger,et al. THE COLONIC EPITHELIUM IN ULCERATIVE COLITIS: AN ENERGY-DEFICIENCY DISEASE? , 1980, The Lancet.
[18] O. P. Dinnick,et al. UNSAFE ANÆSTHETIC SUPPLY SYSTEMS , 1975, The Lancet.
[19] D. Bender,et al. Pellagra with colitis due to a defect in tryptophan metabolism , 1991, European Journal of Pediatrics.
[20] D. Fuchs,et al. Fructose malabsorption is associated with decreased plasma tryptophan. , 1999, Advances in experimental medicine and biology.
[21] R. Xavier,et al. CARD9 impacts colitis by altering gut microbiota metabolism of tryptophan into aryl hydrocarbon receptor ligands , 2016, Nature Medicine.
[22] H. Tilg,et al. Overexpression of indoleamine 2,3-dioxygenase in human inflammatory bowel disease. , 2004, Clinical immunology.
[23] M. Ciorba,et al. Serum Analysis of Tryptophan Catabolism Pathway: Correlation With Crohn's Disease Activity , 2012, Inflammatory bowel diseases.
[24] H Boeing,et al. Reproducibility and relative validity of food group intake in a food frequency questionnaire developed for the German part of the EPIC project. European Prospective Investigation into Cancer and Nutrition. , 1997 .
[25] G. S. Johnson,et al. Control of growth by picolinic acid: differential response of normal and transformed cells. , 1977, Proceedings of the National Academy of Sciences of the United States of America.
[26] K. Walczak,et al. Quinaldic acid inhibits proliferation of colon cancer ht-29 cells in vitro: effects on signaling pathways. , 2015, European journal of pharmacology.
[27] T. Down,et al. A functional methylome map of ulcerative colitis , 2012, Genome research.
[28] Ellen Li,et al. IDO1 and IDO2 Non-Synonymous Gene Variants: Correlation with Crohn's Disease Risk and Clinical Phenotype , 2014, PloS one.
[29] Rob Knight,et al. UCHIME improves sensitivity and speed of chimera detection , 2011, Bioinform..
[30] A. De Luca,et al. Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22. , 2013, Immunity.
[31] Jacques Ravel,et al. An improved dual-indexing approach for multiplexed 16S rRNA gene sequencing on the Illumina MiSeq platform , 2014, Microbiome.
[32] Kyongbum Lee,et al. Microbiome-Derived Tryptophan Metabolites and Their Aryl Hydrocarbon Receptor-Dependent Agonist and Antagonist Activities , 2014, Molecular Pharmacology.
[33] D. Dougherty,et al. L-Tryptophan: Basic Metabolic Functions, Behavioral Research and Therapeutic Indications , 2009, International journal of tryptophan research : IJTR.
[34] M. Ciorba. Indoleamine 2,3 dioxygenase in intestinal disease , 2013, Current opinion in gastroenterology.
[35] J. van os,et al. Depressive Symptoms in Crohn's Disease: Relationship with Immune Activation and Tryptophan Availability , 2013, PloS one.
[36] H. Boeing,et al. Reproducibility and relative validity of energy and macronutrient intake of a food frequency questionnaire developed for the German part of the EPIC project. European Prospective Investigation into Cancer and Nutrition. , 1997, International journal of epidemiology.
[37] M. Imamura,et al. Expression profiles of various transporters for oligopeptides, amino acids and organic ions along the human digestive tract. , 2005, Biochemical pharmacology.
[38] M. Crowell,et al. Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome. , 2004, Gastroenterology.